Classifying insulin regimens--difficulties and proposal for comprehensive new definitions
Affiliations
Affiliations
- Children's Hospital, University Hospital Tuebingen, Germany.
- Department of Medical Psychology OE5430, Hannover Medical School, Germany.
- Institute of Child Health, University of Birmingham, UK.
- Department of Endocrinology and Diabetes, Royal Children's Hospital, Melbourne, Australia.
- Clinique de Diabetologie, Hopital Universitaire des Enfants, Brussels, Belgium.
- Department of Paediatrics, University of Dublin, Trinity College, Ireland.
- Department of Pediatrics, Endocrinology and Diabetes, Medical University of Silesia, Katowice, Poland.
- Faculty of Health Science, University of Copenhagen, Denmark.
- Department of Diabetes in Children and Adolescents, Hôpital Necker - Enfants Malades, Paris, France.
- Department of Paediatrics, DCRTD, Kuwait.
- Department of Diabetes, Royal Hospital for Sick Children, Glasgow, UK.
- DECCP, Clinique Pédiatrique/CHL, Luxembourg.
Collaborators
- Hvidoere Study Group:
H J Aanstoot, J Åman, T Barrett, C de Beaufort, F Cameron, L Castaño, C Castro-Correia, F Chiarelli, G Chiari, T Danne, H Dorchy, L K Fisher, H Hoey, P Jarosz-Chobot, E A Kaprio, M Kocova, K Lange, H B Mortensen, A Neu, P R Njølstad, M Palmert, M Phillip, F Pociot, J J Robert, K J Robertson, E F Roche, E J Schönle, S Shalitin, T Skinner, P Swift, T Urakami, M Vanelli
Abstract
Modern insulin regimens for the treatment of type 1 diabetes are highly individualized. The concept of an individually tailored medicine accounts for a broad variety of different insulin regimens applied. Despite clear recommendations for insulin management in children and adolescents with type 1 diabetes there is little distinctiveness about concepts and the nomenclature is confusing. Even among experts similar terms are used for different strategies. The aim of our review--based on the experiences of the Hvidoere Study Group (HSG)--is to propose comprehensive definitions for current insulin regimens reflecting current diabetes management in childhood and adolescence. The HSG--founded in 1994--is an international group representing 24 highly experienced pediatric diabetes centers, from Europe, Japan, North America and Australia. Different benchmarking studies of the HSG revealed a broad variety of insulin regimens applied in each center, respectively. Furthermore, the understanding of insulin regimens has been persistently different between the centers since more than 20 yr. Not even the terms 'conventional' and 'intensified therapy' were used consistently among all members. Besides the concepts 'conventional' and 'intensified', several other terms for the characterization of insulin regimens are in use: Basal Bolus Concept (BBC), multiple daily injections (MDI), and flexible insulin therapy (FIT) are most frequently used, although none of these expressions is clearly or consistently defined. The proposed new classification for insulin management will be comprehensive, simple, and catchy. Currently available terms were included. This classification may offer the opportunity to compare therapeutic strategies without the currently existing confusion on the insulin regimen.
Keywords: insulin regimens; treatment; type 1 diabetes.
Similar articles
Danne T, Bangstad HJ, Deeb L, Jarosz-Chobot P, Mungaie L, Saboo B, Urakami T, Battelino T, Hanas R; International Society for Pediatric and Adolescent Diabetes.Pediatr Diabetes. 2014 Sep;15 Suppl 20:115-34. doi: 10.1111/pedi.12184.PMID: 25182312 No abstract available.
Rhodes ET, Gong C, Edge JA, Wolfsdorf JI, Hanas R; International Society for Pediatric and Adolescent Diabetes.Pediatr Diabetes. 2014 Sep;15 Suppl 20:224-31. doi: 10.1111/pedi.12172.PMID: 25182316 No abstract available.
Brink S, Joel D, Laffel L, Lee WW, Olsen B, Phelan H, Hanas R; International Society for Pediatric and Adolescent Diabetes.Pediatr Diabetes. 2014 Sep;15 Suppl 20:193-202. doi: 10.1111/pedi.12193.PMID: 25182314 No abstract available.
Insulin therapy in children and adolescents with Type 1 diabetes.
McAssey K, Perlman K, Daneman D.Diabetes Nutr Metab. 1999 Apr;12(2):86-95.PMID: 10554891 Review.
Paediatric diabetes: achieving practical, effective insulin therapy in type 1 and type 2 diabetes.
Danne T, Becker D.Acta Paediatr. 2007 Nov;96(11):1560-70. doi: 10.1111/j.1651-2227.2007.00494.x.PMID: 17937682 Review.
Cited by
Stechova K, Hlubik J, Pithova P, Cikl P, Lhotska L.Nutrients. 2019 May 23;11(5):1148. doi: 10.3390/nu11051148.PMID: 31126048 Free PMC article.
EADSG Guidelines: Insulin Therapy in Diabetes.
Silver B, Ramaiya K, Andrew SB, Fredrick O, Bajaj S, Kalra S, Charlotte BM, Claudine K, Makhoba A.Diabetes Ther. 2018 Apr;9(2):449-492. doi: 10.1007/s13300-018-0384-6. Epub 2018 Mar 5.PMID: 29508275 Free PMC article.